Dr. Ahmet Özyiğit was born in 1981 in Famagusta, Cyprus. He is the youngest of three children of Özgen and Dr. Savaş Özyiğit.
After completing his high school education at Türk Maarif College in 1998, he earned his bachelor's and master's degrees in economics in Kansas, United States. He then received his doctorate in the same field, actively participating in academic research and publishing various scientific articles.
Over time, Dr. Özyiğit turned to medical science and completed his medical education at the University of Nicosia Faculty of Medicine. In addition to his medical education, he earned a master's degree in Clinical Embryology at the University of Leeds, and then pursued postgraduate studies in Endocrinology at the University of South Wales.
Dr. Özyiğit, who shaped her academic and clinical career with a multidisciplinary perspective, continues her clinical studies particularly in the areas of weight management, metabolic health, and healthy aging. An active member of the American Academy of Anti-Aging Medicine, Dr. Özyiğit earned American Board certification as a specialist in Anti-Aging and Regenerative Medicine after completing a fellowship in longevity medicine. In her clinical practice, she offers her patients longevity-focused approaches, weight management programs, reproductive medicine applications for the elderly, and treatments to support brain function.
Dr. Ahmet Özyiğit
Wellness and Anti-aging Applications
Dr. Ahmet Özyiğit
Wellness and Anti-aging Applications
How Does Semaglutide Treatment Help You Lose Weight?
with trade names ozempic or wegovy also referred to as Semaglutide, first "type 2” is a medicine used to treat diabetes. Its mechanism is based on increasing insulin release and reducing glucagon levels by mimicking glucagon-like peptide-1 (GLP-1). Effective regulation of this mechanism ensures more effective blood sugar control. Although originally developed for diabetes management, Semaglutide is gaining more attention for its effect on weight loss. Thanks to the tremendous effect on appetite and weight loss FDA for diabetes treatment in 2017 This drug, which has been approved FDA for weight loss in 2020 Approved by.
Dr. Ahmet Özyiğit has been offering treatments for weight loss for about 3 years, with both the preparation with the trade name Ozempic and the peptide formation of Semaglutide. In these three years Weight loss in over 2000 patients In addition to achieving this goal, we observe that many health-related parameters have improved.
The most important benefit of Semaglutide for weight loss is suppressing appetite and increasing the feeling of fullness It causes a decrease in food intake. With trade names ozempic or wegovy This drug, sold in prepared doses, is also produced by compounding pharmacies in the USA according to its original pharmacological content, and can offer more freedom in terms of dose adjustment. This is one of the most beautiful features of peptides. Since they are small protein compounds found in the body, their formulations can be quite simple. In this way, Purity and not containing any other substances It also has a much more innocent side effect profile compared to other drugs.
The effect of Semaglutide on weight loss, especially fight against obesity It is very important for individuals with diabetes because it provides a very powerful additional tool in managing body weight along with lifestyle changes. This medication, diet and exercise Those who fail to achieve adequate weight loss It is particularly useful for
Obesity is often associated with various health risks, including cardiovascular diseases, diabetes and some types of cancer. In addition, impaired sugar metabolism also causes many diseases. Semaglutide treatment Our patients need regulation of sugar levels, necessary regulation of cholesterol levels, both in the body improvement in inflammation and inflammation markers The fact that we see our patients cardiovascular risks are also significantly reduced shows us.
However, it is important to note that, like any medication, Semaglutide has potential side effects. Common side effects may include nausea, vomiting, diarrhea, or constipation. These side effects are generally quite mild and short-lived. However, if intolerable side effects such as nausea or vomiting occur, the treatment is discontinued.
Although there is no expectation of serious side effects in the long term, it would be better not to use the drug in people with MEN syndrome or people who have experienced pancreatic inflammation.
